Anzeige
Mehr »
Login
Sonntag, 24.10.2021 Börsentäglich über 12.000 News von 675 internationalen Medien
Analysten heben Kursziel massiv an! Chance auf über +140%
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J84E ISIN: US00287Y1091 Ticker-Symbol: 4AB 
Tradegate
22.10.21
21:47 Uhr
93,86 Euro
+0,19
+0,20 %
Branche
Pharma
Aktienmarkt
S&P 100
S&P 500
1-Jahres-Chart
ABBVIE INC Chart 1 Jahr
5-Tage-Chart
ABBVIE INC 5-Tage-Chart
RealtimeGeldBriefZeit
93,5693,9518:58
93,4794,0322.10.

Aktuelle News zur ABBVIE Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrBuckle up AbbVie, Amgen: Biohaven's oral CGRP drug is gaining traction in migraine, doctors' survey shows16
FrAbbVie: Spotlight On Rinvoq Ahead Of Q3 Earnings18
ABBVIE Aktie jetzt für 0€ handeln
MiAbbVie Stock Is Making A Comeback On Inflammatory Drugs - Is It A Buy Now?36
MiChase, after selling last biotech to Allergan, gets cash to start pivotal trials in depression, Parkinson's14
DiOyster Point, with AbbVie and Novartis in its sights, wins first FDA approval for nasal spray to treat dry eye disease36
MoRegeneron, Novo Nordisk, Lilly and AbbVie stake claims on September's list of top TV ad spenders27
MoAbbVie's Humira to face more rivalry as FDA approves first interchangeable biosimilar25
15.10.AbbVie: The Humira Situation Remains Scary53
15.10.AbbVie receives positive opinion from CHMP for injection that treats psoriatic arthritis6
15.10.AbbVie's Risankizumab Gets CHMP Positive Opinion For Active Psoriatic Arthritis Treatment462WASHINGTON (dpa-AFX) - AbbVie (ABBV) said that the European Medicines Agency's or EMA Committee for Medicinal Products for Human Use or CHMP recommended the approval of Risankizumab (SKYRIZI)...
► Artikel lesen
15.10.AbbVie Receives CHMP Positive Opinion for Risankizumab3
15.10.AbbVie gets EMA CHMP positive recommendation for psoriatic arthritis treatment SKYRIZI5
13.10.AbbVie: A Top Dividend Stock For The Long Term50
13.10.Allergan With Settle With Restasis Payers For $30M15
12.10.AbbVie Inc.: Dissect Its Growth Sustainability And Capital Allocation Like Buffett33
11.10.AbbVie's Botox patent lawsuit is 'very unlikely to derail' Revance's rival launch: analysts29
11.10.AbbVie Inc. Launches Series of Initiatives to Support Breast Cancer Awareness8
10.10.Eli Lilly, AbbVie favorites at JPMorgan as big pharma set for Q3 earnings53
08.10.Mirati teams with Sanofi on PhI/II trial for KRAS treatment combo; AbbVie loses in latest Humira biosimilar development17
08.10.AbbVie Vs. Moderna Stock: Which Is The Better Buy?38
Seite:  Weiter >>
449 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
8,4,44